Medtronic and its subsidiary Given Imaging have recalled certain Bravo CF capsule delivery devices after Medtronic reported 184 serious injuries associated with the issue as of Aug. 10.
Medtronic said the Bravo CF capsule may fail to attach to a patient’s esophagus or fail to detach from the delivery device as intended, according to an Aug. 31 FDA news release. The failures may result from a problem with the component controlling the capsule’s deployment. Potential risks include aspiration or inhalation, esophageal perforation, airway obstruction, bleeding, esophageal laceration, delayed diagnosis and a foreign body remaining in the patient.
Medtronic sent affected customers a letter Aug. 6 instructing them to immediately identify and quarantine unused affected devices and return them for replacement. The affected products include the Bravo CF capsule delivery device 5-pack (FGS-0635) and 1-pack (FGS-0636). All affected lot numbers have expiration dates on or before Oct. 20, 2027.
A subset of affected lots was previously included in a June 2025 recall notification.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
